BODY LANGUAGE VITAMIN CO. L.C – Trademark Portfolio
Entity Type: 16
BODY LANGUAGE VITAMIN CO. L.C holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PEAK365, PEAK365 NUTRITION, and BODY LANGUAGE VITAMINS. The owner is based in West Bloomfield, MI.
6566 Bristol Dr
West Bloomfield, MI 48322
Showing of trademarks Trademarks
Trademark Classifications
BODY LANGUAGE VITAMIN CO. L.C's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does BODY LANGUAGE VITAMIN CO. L.C have?
BODY LANGUAGE VITAMIN CO. L.C has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does BODY LANGUAGE VITAMIN CO. L.C file in?
BODY LANGUAGE VITAMIN CO. L.C files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are BODY LANGUAGE VITAMIN CO. L.C's most well-known trademarks?
BODY LANGUAGE VITAMIN CO. L.C's registered trademark portfolio includes well-known marks such as PEAK365, PEAK365 NUTRITION, and BODY LANGUAGE VITAMINS. These are among 3 currently registered trademarks in the portfolio.
What is BODY LANGUAGE VITAMIN CO. L.C's trademark registration success rate?
BODY LANGUAGE VITAMIN CO. L.C has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.